There were 360 press releases posted in the last 24 hours and 442,591 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Galera Therapeutics Raises $150 Million for GC4419 Phase 3 Trial and Pre-Commercialization Activities in Lead Indication

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image